Oral naltrexone as an adjuvant therapy for refractory atopic dermatitis (2015)
Source: Journal of the American Academy of dermatology. Conference titles: Annual Meeting of the American Academy of Dermatology. Unidade: FM
Subjects: DERMATITE, SISTEMA NERVOSO CENTRAL, SINAIS E SINTOMAS, USOS TERAPÊUTICOS, ANTAGONISMO DE DROGAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
TIRICO, Maria Claudia et al. Oral naltrexone as an adjuvant therapy for refractory atopic dermatitis. Journal of the American Academy of dermatology. California: Faculdade de Medicina, Universidade de São Paulo. Disponível em: http://www.sciencedirect.com/science/article/pii/S0190962215004272. Acesso em: 27 nov. 2025. , 2015APA
Tirico, M. C., Samorano, L. P., Orfali, R. L., & Aoki, V. (2015). Oral naltrexone as an adjuvant therapy for refractory atopic dermatitis. Journal of the American Academy of dermatology. California: Faculdade de Medicina, Universidade de São Paulo. Recuperado de http://www.sciencedirect.com/science/article/pii/S0190962215004272NLM
Tirico MC, Samorano LP, Orfali RL, Aoki V. Oral naltrexone as an adjuvant therapy for refractory atopic dermatitis [Internet]. Journal of the American Academy of dermatology. 2015 ; 72( 5): AB75.[citado 2025 nov. 27 ] Available from: http://www.sciencedirect.com/science/article/pii/S0190962215004272Vancouver
Tirico MC, Samorano LP, Orfali RL, Aoki V. Oral naltrexone as an adjuvant therapy for refractory atopic dermatitis [Internet]. Journal of the American Academy of dermatology. 2015 ; 72( 5): AB75.[citado 2025 nov. 27 ] Available from: http://www.sciencedirect.com/science/article/pii/S0190962215004272
